Stealth BioTherapeutics

FDA stop sign
Biotech

FDA delays decision on Stealth's ultrarare disease med

It looks like Stealth will have to remain patient a while longer before it finally finds out whether its Barth syndrome treatment will be approved.
James Waldron Jan 23, 2025 9:45am
FDA Adcomm

After agony, FDA adcomm favors Stealth's ultra-rare disease drug

Oct 10, 2024 6:20pm
stealth cloak mask hide sneaky shady

Stealth handed cloaking device as go-private merger advances

Aug 1, 2022 12:53pm
stealth fighter jets sneak hide

Stealth could get sneakier with Morningside's go-private pitch

Jun 27, 2022 11:00am
boardroom

Stealth granted FDA meeting to revive elamipretide filing

Jun 14, 2022 10:10am
fail

Stealth stumbles again as AMD joins list of clinical trial flops

May 2, 2022 9:05am